{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:08:35Z","timestamp":1789456115212,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":179,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.jcmgh.2026.101845","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:15:47Z","timestamp":1783091747000},"page":"101845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatocyte Transforming Growth Factor-\u03b2\u2013Oxysterol-Binding Protein-Related Protein 3 Signaling Axis Promotes Hepatic Stellate Cell Activation and Liver Fibrogenesis in Mice"],"prefix":"10.1016","volume":"20","author":[{"given":"Jiashi","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuee","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9237-9350","authenticated-orcid":false,"given":"Lei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2026.101845_bib1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.cgh.2024.08.020","article-title":"Global prevalence of advanced liver fibrosis and cirrhosis in the general population: a systematic review and meta-analysis","volume":"23","author":"Zamani","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101845_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70001","article-title":"The global burden of cirrhosis and other chronic liver diseases in 2021","volume":"45","author":"Tham","year":"2025","journal-title":"Liver Int"},{"key":"10.1016\/j.jcmgh.2026.101845_bib3","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1136\/gutjnl-2024-332917","article-title":"Prevalence of steatotic liver disease, advanced fibrosis and cirrhosis among community-dwelling overweight and obese individuals in the USA","volume":"73","author":"Yang","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2026.101845_bib4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101845_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41573-024-01084-2","article-title":"Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)","volume":"24","author":"Do","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jcmgh.2026.101845_bib6","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1097\/HEP.0000000000001254","article-title":"Comparison of pharmacological therapies in metabolic dysfunction-associated steatohepatitis for fibrosis regression and MASH resolution: systematic review and network meta-analysis","volume":"82","author":"Souza","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101845_bib7","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jcmgh.2026.101845_bib8","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jhbp.245","article-title":"Recent advancement of molecular mechanisms of liver fibrosis","volume":"22","author":"Seki","year":"2015","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jcmgh.2026.101845_bib9","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101845_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat0344","article-title":"Hepatocyte notch activation induces liver fibrosis in nonalcoholic steatohepatitis","volume":"10","author":"Zhu","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcmgh.2026.101845_bib11","article-title":"Understanding the cellular interactome of non-alcoholic fatty liver disease","volume":"4","author":"Wallace","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jcmgh.2026.101845_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41467-020-20303-z","article-title":"Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH","volume":"12","author":"Dong","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2026.101845_bib13","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.gastro.2013.01.056","article-title":"Transforming growth factor-beta signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1","volume":"144","author":"Yang","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101845_bib14","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/febs.13665","article-title":"TGF-beta signalling and liver disease","volume":"283","author":"Fabregat","year":"2016","journal-title":"FEBS J"},{"key":"10.1016\/j.jcmgh.2026.101845_bib15","doi-asserted-by":"crossref","first-page":"121S","DOI":"10.1097\/01.alc.0000189284.98684.22","article-title":"Anti-TGF-beta strategies for the treatment of chronic liver disease","volume":"29","author":"Breitkopf","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jcmgh.2026.101845_bib16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1053\/j.gastro.2021.04.064","article-title":"TGF-beta signaling in liver, pancreas, and gastrointestinal diseases and cancer","volume":"161","author":"Gough","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101845_bib17","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/cells8111419","article-title":"TGF-beta in hepatic stellate cell activation and liver fibrogenesis-updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jcmgh.2026.101845_bib18","article-title":"Transforming growth factor beta latency: a mechanism of cytokine storage and signalling regulation in liver homeostasis and disease","volume":"4","author":"Li","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jcmgh.2026.101845_bib19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/hep.26698","article-title":"Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101845_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911696","article-title":"Hepatocyte-specific Smad4 deficiency alleviates liver fibrosis via the p38\/p65 pathway","volume":"23","author":"Wei","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2026.101845_bib21","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-beta signaling in health and disease","volume":"186","author":"Massague","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2026.101845_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay8798","article-title":"Targeting acid ceramidase inhibits YAP\/TAZ signaling to reduce fibrosis in mice","volume":"12","author":"Alsamman","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcmgh.2026.101845_bib23","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jcmgh.2021.06.003","article-title":"Fatty acids activate the transcriptional coactivator YAP1 to promote liver fibrosis via p38 mitogen-activated protein kinase","volume":"12","author":"Salloum","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101845_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1440-1797.2007.00913.x","article-title":"Transcription factor AP-1 regulates TGF-beta(1)-induced expression of aldose reductase in cultured human mesangial cells","volume":"13","author":"Jiang","year":"2008","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.jcmgh.2026.101845_bib25","doi-asserted-by":"crossref","first-page":"30488","DOI":"10.1073\/pnas.2017056117","article-title":"FoxO1 is a crucial mediator of TGF-beta\/TAK1 signaling and protects against osteoarthritis by maintaining articular cartilage homeostasis","volume":"117","author":"Wang","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2026.101845_bib26","doi-asserted-by":"crossref","first-page":"8949","DOI":"10.1074\/jbc.274.13.8949","article-title":"ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-beta signaling","volume":"274","author":"Sano","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcmgh.2026.101845_bib27","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1053\/j.gastro.2017.12.022","article-title":"Hedgehog-YAP signaling pathway regulates glutaminolysis to control activation of hepatic stellate cells","volume":"154","author":"Du","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101845_bib28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jhep.2015.04.011","article-title":"The hippo pathway effector YAP controls mouse hepatic stellate cell activation","volume":"63","author":"Mannaerts","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101845_bib29","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400813RR","article-title":"YAP activation in liver macrophages via depletion of MST1\/MST2 enhances liver inflammation and fibrosis in MASLD","volume":"38","author":"Zhang","year":"2024","journal-title":"FASEB J"},{"key":"10.1016\/j.jcmgh.2026.101845_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1060","article-title":"TGF-beta\/Smads signaling pathway, Hippo-YAP\/TAZ signaling pathway, and VEGF: their mechanisms and roles in vascular remodeling related diseases","volume":"11","author":"Liu","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jcmgh.2026.101845_bib31","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1007\/s00018-018-2795-y","article-title":"Bridging the molecular and biological functions of the oxysterol-binding protein family","volume":"75","author":"Pietrangelo","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jcmgh.2026.101845_bib32","article-title":"Oxysterol-binding protein: new insights into lipid transport functions and human diseases","volume":"1868","author":"Lin","year":"2023","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.jcmgh.2026.101845_bib33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.yexcr.2014.10.019","article-title":"OSBP-related protein 3 (ORP3) coupling with VAMP-associated protein A regulates R-Ras activity","volume":"331","author":"Weber-Boyvat","year":"2015","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jcmgh.2026.101845_bib34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1172\/JCI85499","article-title":"Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease","volume":"127","author":"Stein","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcmgh.2026.101845_bib35","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1124\/mol.105.017483","article-title":"Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression","volume":"69","author":"Jinnin","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jcmgh.2026.101845_bib36","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.bbrc.2018.06.072","article-title":"SIS3, a specific inhibitor of smad3, attenuates bleomycin-induced pulmonary fibrosis in mice","volume":"503","author":"Shou","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcmgh.2026.101845_bib37","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1042\/BST0341018","article-title":"Dual-specificity phosphatase 1: a critical regulator of innate immune responses","volume":"34","author":"Abraham","year":"2006","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jcmgh.2026.101845_bib38","doi-asserted-by":"crossref","first-page":"6869","DOI":"10.1080\/21655979.2021.1972194","article-title":"E2F transcription factor 1 (E2F1) promotes the transforming growth factor TGF-beta1 induced human cardiac fibroblasts differentiation through promoting the transcription of CCNE2 gene","volume":"12","author":"Liao","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.jcmgh.2026.101845_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.101957","article-title":"Suppression of hepatic ChREBP\u237a-CYP2C50 axis-driven fatty acid oxidation sensitizes mice to diet-induced MASLD\/MASH","volume":"85","author":"Zhang","year":"2024","journal-title":"Mol Metab"},{"key":"10.1016\/j.jcmgh.2026.101845_bib40","doi-asserted-by":"crossref","first-page":"13533","DOI":"10.1096\/fj.201903292RR","article-title":"Hepatic E4BP4 induction promotes lipid accumulation by suppressing AMPK signaling in response to chemical or diet-induced ER stress","volume":"34","author":"Yang","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.jcmgh.2026.101845_bib41","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"OPN-mediated crosstalk between hepatocyte E4BP4 and hepatic stellate cells promotes MASH-associated liver fibrosis","volume":"11","author":"Wang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jcmgh.2026.101845_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-85508-y","article-title":"Non-invasive liver fibrosis markers are increased in obese individuals with non-alcoholic fatty liver disease and the metabolic syndrome","volume":"15","author":"Askeland","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2026.101845_bib43","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/oby.24130","article-title":"Obesity increases the risk of hepatic fibrosis in young adults with type 2 diabetes mellitus: the need to screen","volume":"32","author":"Sharma","year":"2024","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jcmgh.2026.101845_bib44","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/alcalc\/agz036","article-title":"Alcoholic hepatitis: a review","volume":"54","author":"Hosseini","year":"2019","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.jcmgh.2026.101845_bib45","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1006\/jmcc.2000.1215","article-title":"CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis","volume":"32","author":"Chen","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jcmgh.2026.101845_bib46","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/jop.12430","article-title":"THBS1 is induced by TGFB1 in the cancer stroma and promotes invasion of oral squamous cell carcinoma","volume":"45","author":"Pal","year":"2016","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.jcmgh.2026.101845_bib47","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/00002281-200211000-00009","article-title":"Pathogenesis of fibrosis: role of TGF-beta and CTGF","volume":"14","author":"Ihn","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jcmgh.2026.101845_bib48","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1186\/1755-1536-5-S1-S24","article-title":"CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis","volume":"5","author":"Lipson","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.jcmgh.2026.101845_bib49","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/jgm.894","article-title":"Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats","volume":"8","author":"Li","year":"2006","journal-title":"J Gene Med"},{"key":"10.1016\/j.jcmgh.2026.101845_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2023.149369","article-title":"Thrombospondin-1 promotes liver fibrosis by enhancing TGF-beta action in hepatic stellate cells","volume":"693","author":"Imamori","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcmgh.2026.101845_bib51","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3390\/cells13110960","article-title":"Combined insults of a MASH diet and alcohol binges activate intercellular communication and neutrophil recruitment via the NLRP3-IL-1beta axis in the liver","volume":"13","author":"Babuta","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.jcmgh.2026.101845_bib52","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jhep.2019.12.016","article-title":"IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease","volume":"72","author":"Ma","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101845_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066106","article-title":"The chemokine CCL3 promotes experimental liver fibrosis in mice","volume":"8","author":"Heinrichs","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2026.101845_bib54","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s12276-022-00781-5","article-title":"Hyaluronan synthase 2, a target of miR-200c, promotes carbon tetrachloride-induced acute and chronic liver inflammation via regulation of CCL3 and CCL4","volume":"54","author":"Kim","year":"2022","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jcmgh.2026.101845_bib55","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0023677215571192","article-title":"The carbon tetrachloride model in mice","volume":"49","author":"Scholten","year":"2015","journal-title":"Lab Anim"},{"key":"10.1016\/j.jcmgh.2026.101845_bib56","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/cancers10040121","article-title":"Ubiquitin-Dependent Regulation of the Mammalian Hippo Pathway: Therapeutic Implications for Cancer","volume":"10","author":"Nguyen","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jcmgh.2026.101845_bib57","first-page":"1455","article-title":"Ubiquitination-deubiquitination in the hippo signaling pathway (Review)","volume":"41","author":"Liu","year":"2019","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jcmgh.2026.101845_bib58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1097-2765(02)00776-1","article-title":"Akt phosphorylates the yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis","volume":"11","author":"Basu","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.jcmgh.2026.101845_bib59","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.1602907","article-title":"Inactivation of YAP oncoprotein by the hippo pathway is involved in cell contact inhibition and tissue growth control","volume":"21","author":"Zhao","year":"2007","journal-title":"Genes Dev"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26001232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26001232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:23:59Z","timestamp":1789453439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X26001232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2352345X26001232"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101845","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocyte Transforming Growth Factor-\u03b2\u2013Oxysterol-Binding Protein-Related Protein 3 Signaling Axis Promotes Hepatic Stellate Cell Activation and Liver Fibrogenesis in Mice","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101845","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101845"}}